{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:17:56Z","timestamp":1778865476165,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jns.2017.04.045","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T17:15:28Z","timestamp":1493399728000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels"],"prefix":"10.1016","volume":"378","author":[{"given":"T.","family":"Yeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Y.H.","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5894-8839","authenticated-orcid":false,"given":"K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jns.2017.04.045_bb0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jnnp-2013-305218","article-title":"Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre","volume":"85","author":"Paterson","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2017.04.045_bb0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00415-014-7588-0","article-title":"An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre","volume":"262","author":"Huda","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.04.045_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol."},{"issue":"18","key":"10.1016\/j.jns.2017.04.045_bb0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies","volume":"86","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jns.2017.04.045_bb0025","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00415-012-6554-y","article-title":"Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease","volume":"259","author":"Fujita","year":"2012","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2017.04.045_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jnnp-2014-308695","article-title":"Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease","volume":"86","author":"Rossi","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.jns.2017.04.045_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jns.2017.04.045_bb0040","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.jns.2017.04.045_bb0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2017.04.045_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","article-title":"Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes","volume":"133","author":"Irani","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2017.04.045_bb0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2017.04.045_bb0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2017.04.045_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 10","key":"10.1016\/j.jns.2017.04.045_bb0075","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"issue":"18","key":"10.1016\/j.jns.2017.04.045_bb0080","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1212\/WNL.0000000000002644","article-title":"Voltage-gated potassium channel antibodies: game over","volume":"86","author":"Graus","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2017.04.045_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2017.04.045_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnmol.2016.00037","article-title":"Detection and characterization of autoantibodies to neuronal cell-surface antigens in the central nervous system","volume":"9","author":"van Coevorden-Hameete","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2017.04.045_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2017.04.045_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-444-63432-0.00012-8","article-title":"Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies","volume":"133","author":"De Bruijn","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2017.04.045_bb0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(13)70072-3","article-title":"Prevalence and treatment of anti-NMDA receptor encephalitis \u2013 authors' reply","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2017.04.045_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T03:53:26Z","timestamp":1535860406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17302861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":21,"alternative-id":["S0022510X17302861"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.04.045","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}